Tag: chemistry
-
Trial Shows Synthetic Antibody Slows Cognitive Decline
Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease.
-
Nasal Spray Shown to Stop Covid-19 Infection, Disease
An antiviral nasal spray is shown in tests with lab mice to prevent infection from SARS-CoV-2 viruses and reduce disease-causing cytokines.
-
RNA Manufacturer Goes Public in $282M Merger
A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition.
-
Portable Testing Device IDs Covid-19 Variants
A low-cost device is being developed that analyzes saliva samples for SARS-CoV-2 viral mutations, and returns results in about one hour.
-
Protein Chemistry Biotech Acquired in $2B Deal
Drug maker Bayer is acquiring a company discovering new therapies with a technology that reveals complex protein targets considered difficult to address.
-
Fine-Tuning Process Devised for Gene Therapies
Researchers designed a technique to adjust the volume of proteins from gene therapy released into patients, providing more control for complex diseases.
-
Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds
A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds.
-
3-D Printed Scaffold Helps Regrow Soft Tissue
Researchers developed a biodegradable polymer for printed implant scaffolds that in lab rodents maintains its shape to encourage cell and tissue growth.
-
Face Mask Sensor Detects Covid-19 Virus
Engineers designed sensors made from bioactive materials integrated into fabrics, beginning with a face mask that detects the SARS-CoV-2 virus.
-
Patent Awarded for Safer Cancer Drug Delivery
A pharmaceutical R&D company is receiving a patent for its process that encapsulates and better targets chemotherapy drugs for cancer patients.